Buy Like Buffett
Watchlist

Flagship explainer

What drives ADAPTIMMUNE THERAPEUTICS PLC’s return on equity?

ROE is five filed business factors multiplied together.

DuPont return on equity factor treeReturn on equity branches into tax burden, interest burden, operating margin, asset turnover, and the equity multiplier.Return on equity−276%Tax burden105%net income ÷ pretax incomeInterest burden98%pretax ÷ operating incomeOperating margin−39%operating income ÷ revenueAsset turnover0.67×revenue ÷ average assetsEquity multiplier10.29×average assets ÷ average equityAs of 2024-12-31 · 2 SEC filing sourcesBuy Like Buffett · buylikebuffett.com
DuPont source inputs
InputValueFiscal yearSource
−$70.8MFY2024
  • 10-K · FY 2024Filing detailsAccession 0001558370-25-003544 · filed Mar 24, 2025
Income before tax−$67.2MFY2024
  • 10-K · FY 2024Filing detailsAccession 0001558370-25-003544 · filed Mar 24, 2025
Operating income−$68.8MFY2024
  • 10-K · FY 2024Filing detailsAccession 0001558370-25-003544 · filed Mar 24, 2025
$178MFY2024
  • 10-K · FY 2024Filing detailsAccession 0001558370-25-003544 · filed Mar 24, 2025
Ending assets$246MFY2024
  • 10-K · FY 2024Filing detailsAccession 0001558370-25-003544 · filed Mar 24, 2025
Beginning assets$283MFY2023
  • 10-K · FY 2023Filing detailsAccession 0001558370-25-003544 · filed Mar 24, 2025
$11.8MFY2024
  • 10-K · FY 2024Filing detailsAccession 0001558370-25-003544 · filed Mar 24, 2025
$39.5MFY2023
  • 10-K · FY 2023Filing detailsAccession 0001558370-25-003544 · filed Mar 24, 2025
Source: · event Dec 31, 2024 · retrieved Oct 18, 2026 · annual-row source set
Embed this chart

View the full ADAPTIMMUNE THERAPEUTICS PLC analysis at Buy Like Buffett